Women's Health Research Program and Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio 45219, USA.
Am J Med. 2009 Dec;122(12 Suppl):S31-43. doi: 10.1016/j.amjmed.2009.09.009.
The presentation of fibromyalgia is heterogeneous, and the treatment approach should be individualized for each patient, depending on the severity of the patient's pain, the presence of other symptoms or comorbidities, and the degree of functional impairment. The management of fibromyalgia includes the identification and treatment of all pain sources that may be present in addition to fibromyalgia, such as peripheral pain generators (e.g., comorbid osteoarthritis or neuropathic pain) or visceral pain (e.g., comorbid irritable bowel syndrome). It is also important to address other symptoms or disorders that commonly occur in patients with fibromyalgia, such as fatigue, sleep disturbances, cognitive impairment, stiffness, and mood or anxiety disorders. Finally, the treatment should strive to improve the patient's function and global health status. In most cases, the management of fibromyalgia involves both pharmacologic and nonpharmacologic treatments. This report provides an in-depth review of randomized, controlled trials for pharmacologic and nonpharmacologic approaches to fibromyalgia therapy.
纤维肌痛的表现具有异质性,治疗方法应根据患者疼痛的严重程度、是否存在其他症状或合并症以及功能障碍的程度,为每位患者量身定制。纤维肌痛的治疗包括识别和治疗除纤维肌痛以外可能存在的所有疼痛源,例如外周疼痛发生器(例如,合并骨关节炎或神经病理性疼痛)或内脏疼痛(例如,合并肠易激综合征)。解决纤维肌痛患者中常见的其他症状或疾病也很重要,例如疲劳、睡眠障碍、认知障碍、僵硬以及情绪或焦虑障碍。最后,治疗应努力改善患者的功能和整体健康状况。在大多数情况下,纤维肌痛的治疗包括药物和非药物治疗。本报告深入回顾了纤维肌痛治疗的药物和非药物方法的随机对照试验。